Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Marrone Bio Innovations Inc reaffirms FY 2014 revenue guidance

Thursday, 6 Mar 2014 04:15pm EST 

Marrone Bio Innovations Inc:Expects FY 2014 net revenues to continue to at least double compared to FY 2013.Reported revenue of $14.5 million in FY 2013.FY 2014 revenue of $37 million - Thomson Reuters I/B/E/S. 

Company Quote

20 Apr 2015